HeartFlow Overview
- Year Founded
-
1995
- Status
-
Public
- Employees
-
843
- Stock Symbol
-
HTFL
- Share Price
-
$48.44
- (As of Friday Closing)
HeartFlow General Information
Description
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
Contact Information
Website
www.heartflow.comCorporate Office
- 331 East Evelyn Avenue
- Mountain View, CA 94041
- United States
Corporate Office
- 331 East Evelyn Avenue
- Mountain View, CA 94041
- United States
HeartFlow Timeline
HeartFlow Stock Performance
As of 13-Nov-2026, HeartFlow’s stock price is $48.44. Its current market cap is $4.26B with 87.9M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $48.44 | $59.92 | $20.13 - $60.66 | $4.26B | 87.9M | 2.09M | -$0.92 |
HeartFlow Financials Summary
As of 30-Sep-2026, HeartFlow has a trailing 12-month revenue of $239M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 4,190,519 | 2,212,999 | ||
| Revenue | 238,656 | 176,034 | 125,808 | 87,174 |
| EBITDA | (79,351) | (98,659) | (69,578) | (68,238) |
| Net Income | (79,023) | (116,791) | (96,426) | (95,655) |
| Total Assets | 355,339 | 359,452 | 118,704 | 185,051 |
| Total Debt | 25,933 | 22,054 | 160,384 | 160,600 |
HeartFlow Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
HeartFlow Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
HeartFlow Comparisons
Industry
Financing
Details
HeartFlow Competitors (9)
One of HeartFlow’s 9 competitors is Lunit, a Formerly VC-backed company based in Seoul, South Korea.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Lunit | Formerly VC-backed | Seoul, South Korea | ||||
| NantHealth | Formerly VC-backed | Lewisville, TX | ||||
| Advantis Medical Imaging | Venture Capital-Backed | Eindhoven, Netherlands | ||||
| Vista (Decision/Risk Analysis) | Venture Capital-Backed | Redwood City, CA | ||||
| MIM Software | Corporate Backed or Acquired | Cleveland, OH |
HeartFlow Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
HeartFlow Patents
HeartFlow Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260260761-A1 | Cardiovascular risk prediction using multiple instance learning and lesion-aware models | Pending | 28-Feb-2025 | ||
| WO-2026183399-A1 | Cardiovascular risk prediction using multiple instance learning and lesion-aware models | Pending | 28-Feb-2025 | ||
| US-20260253286-A1 | Systems and methods for generating counterfactual images using counterfactual fine-tuning | Pending | 26-Feb-2025 | ||
| WO-2026183167-A1 | Systems and methods for generating counterfactual images using counterfactual fine-tuning | Pending | 26-Feb-2025 | ||
| US-20260278784-A1 | Multimodal data fusion for coronary heart disease diagnostics and prognostics from non-invasive imaging | Pending | 16-Jan-2025 | G06T7/0012 |
HeartFlow Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
HeartFlow Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
HeartFlow ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Health Care IT Services
Subindustry
Rank
Percentile
HeartFlow FAQs
-
When was HeartFlow founded?
HeartFlow was founded in 1995.
-
Where is HeartFlow headquartered?
HeartFlow is headquartered in Mountain View, CA.
-
What is the size of HeartFlow?
HeartFlow has 843 total employees.
-
What industry is HeartFlow in?
HeartFlow’s primary industry is Decision/Risk Analysis.
-
Is HeartFlow a private or public company?
HeartFlow is a Public company.
-
What is HeartFlow’s stock symbol?
The ticker symbol for HeartFlow is HTFL.
-
What is the current stock price of HeartFlow?
As of 13-Nov-2026 the stock price of HeartFlow is $48.44.
-
What is the current market cap of HeartFlow?
The current market capitalization of HeartFlow is $4.26B.
-
What is HeartFlow’s current revenue?
The trailing twelve month revenue for HeartFlow is $239M.
-
Who are HeartFlow’s competitors?
Lunit, NantHealth, Advantis Medical Imaging, Vista (Decision/Risk Analysis), and MIM Software are some of the 9 competitors of HeartFlow.
-
What is HeartFlow’s annual earnings per share (EPS)?
HeartFlow’s EPS for 12 months was -$0.92.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
